Building on a $20 million funding round announced last month, Propeller Health said today that it landed an investment of an undisclosed amount from McKesson Ventures. The company is looking to expand its digital therapeutics business beyond devices that manage the treatment of chronic respiratory diseases. Get the full story at our sister site, Drug Delivery Business News.
Propeller raises $20m and prepares to extend reach beyond digital inhalers
Digital therapeutics company Propeller Health and drug-delivery device-maker Aptar Pharma are teaming up, yet again, to develop an array of connected drug-delivery devices. The pair has worked together in the past – in 2016, the companies launched the world’s first fully-integrated connected metered dose inhaler. Get the full story at our sister site, Drug Delivery Business News.
Study: Propeller’s digital asthma tech informs policy, improves health
Results from a large, real-world study of asthma patients found that digital health technology can improve patient outcomes and inform city-planning policy, Propeller Health touted this month. The company teamed up with local government in Louisville, Kentucky and a nonprofit group to assess how environmental conditions can influence asthma symptoms using connected inhalers and a data-sharing platform. […]
Propeller Health, Express Scripts ink smart inhaler sensor deal
Propeller Health said today it inked a strategic partnership deal with Express Scripts (NSDQ:ESRX) to provide Propeller’s digital solutions to Express Script members. Through the deal, St. Louis-based Express Script members will be able to use inhaler sensors and connected mobile applications to manage their asthma or chronic obstructive pulmonary disease. The companies touted it as the largest […]
Propeller Health launches API to provide local asthma conditions to orgs, patients
Earlier this week, Propeller Health released an application programming interface to give local asthma conditions to anyone within the U.S. who is interested in using that data. The Air by Propeller API is a free service that uses a machine-learning model based on millions of days of anonymous asthma symptom data and environmental data. The model uses […]
Propeller Health: From hardware startup to analytics leader
Seven years after the digital respiratory startup Propeller Health launched, co-founder and chief technology officer Greg Tracy told a crowd at this year’s Medical Sensors Design Conference that what started as an attempt to build sensors for respiratory devices has slowly evolved into a “hardware-enabled software company.” “We thought that we were going to go build […]
Collecting purposeful data in the era of connected health devices
Connectivity, one of the newest buzzwords in the medical device lexicon, is becoming more and more integral to device design and development. Research shows that connected health devices can improve patient outcomes by increasing adherence and reducing dosing variability. Mark David Tuckwell, head of electronics, software & systems at Sagentia, says connected device can also provide crucial information to help […]
Propeller Health, Novartis ink collaboration for connected inhaler
Propeller Health said today that it landed a collaborative agreement with Novartis (NYSE:NVS) to develop a custom add-on sensor for the Breezhaler inhaler. The partnership is focused on patients with chronic obstructive pulmonary disease in Europe. The Breezhaler is a capsule-based, dry powder inhaler and is a part of Novartis’ portfolio of COPD therapies. The custom […]
Propeller inks deal with Italian spirometer maker
Propeller Health said today that it inked a collaborative deal with Medical International Research to integrate MIR’s mobile and clinical spirometers into the Propeller system. Spirometry, measuring lung function by how much air is inhaled and exhaled, can help provide a physiological measurement for disease progression in patients with asthma or chronic obstructive pulmonary disease. […]
Propeller wins FDA nod for connected GSK Ellipta inhaler
Propeller Health said today that it won 510(k) clearance from the FDA to market its Propeller platform with GlaxoSmithKline‘s (NYSE:GSK) Ellipta inhaler. A sensor for the dry powder inhaler was built as a part of a 1 year-long development and R&D collaboration between Propeller and GSK. This marks the 8th clearance for Propeller’s connected inhaler […]
Propeller Health raises $22m in Series C
Propeller Health said today it closed a $21.5 million Series C round of financing, with funds salted to help expand the company’s digitally-guided therapy platform. The fund was joined by newly invested 3M Ventures, S.R. One, Limited and Hikma Ventures and by previous investors Safeguard Scientifics and Social Capital. “Propeller is bringing a smarter, digitally-guided […]
MassDevice Network
@MassDevice
LinkedIn
Google+